US Stock MarketDetailed Quotes

AVDL Avadel Pharmaceuticals

Watchlist

15.490
-0.450-2.82%

Close May 17 16:00 ET

16.420
+0.930+6.00%

Post 19:03 ET

1.49BMarket Cap-8510P/E (TTM)

Avadel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

1.75%-29.7M

-82.79%-128.51M

-82.41%-28.03M

-461.90%-38.23M

-127.27%-32.02M

11.20%-30.23M

9.06%-70.3M

31.72%-15.37M

67.97%-6.8M

-38.78%-14.09M

Net income from continuing operations

11.18%-27.34M

-16.59%-160.28M

-4.87%-28.79M

-80.06%-36.27M

-1.56%-64.43M

-16.50%-30.78M

-77.77%-137.46M

-23.09%-27.45M

8.44%-20.15M

-224.01%-63.44M

Operating gains losses

----

--13.13M

--0

----

Depreciation and amortization

-7.99%541K

18.29%1.77M

-103.07%-18K

48.38%595K

143.32%601K

127.03%588K

83.19%1.49M

191.54%586K

103.55%401K

24.12%247K

Deferred tax

----

--0

----

266.12%26.03M

102.51%109K

100.90%46K

917.35%30.19M

Other non cash items

-138.41%-719K

-49.86%4.06M

-34.00%1.61M

-102.48%-55K

-74.33%630K

90.83%1.87M

251.45%8.09M

412.82%2.44M

263.01%2.22M

482.90%2.45M

Change In working capital

-120.72%-7.57M

-112.22%-3M

-162.01%-4.35M

-164.18%-5.62M

-34.15%10.41M

51.28%-3.43M

564.01%24.54M

935.55%7.02M

225.34%8.76M

50.48%15.8M

-Change in receivables

---10.61M

-34,163.33%-10.22M

-196,700.00%-5.9M

-155,666.67%-4.67M

618.37%352K

--0

-98.93%30K

101.06%3K

-400.00%-3K

-98.37%49K

-Change in inventory

---1.26M

---9.53M

---4.25M

---3.85M

---1.44M

--0

----

-Change in prepaid assets

-47.49%-6.09M

-110.15%-3.13M

-59.89%1.15M

-99.16%123K

-101.75%-269K

-100.73%-4.13M

7,119.36%30.82M

844.68%2.87M

379.78%14.64M

2,338.57%15.36M

-Change in payables and accrued expense

1,241.05%10.94M

739.95%18.44M

-11.00%3.98M

131.94%1.74M

749.39%11.9M

124.73%816K

-156.19%-2.88M

53.80%4.47M

-745.44%-5.45M

-80.74%1.4M

-Change in other working capital

-380.17%-557K

142.05%1.44M

306.56%661K

340.37%1.04M

86.25%-139K

93.04%-116K

9.50%-3.43M

79.50%-320K

64.29%-431K

-150.87%-1.01M

Cash from discontinued investing activities

Operating cash flow

1.75%-29.7M

-82.79%-128.51M

-82.41%-28.03M

-461.90%-38.23M

-127.27%-32.02M

11.20%-30.23M

9.06%-70.3M

31.72%-15.37M

67.97%-6.8M

-38.78%-14.09M

Investing cash flow

Cash flow from continuing investing activities

322.17%21.39M

-162.85%-50.09M

22.09%27.93M

289.10%9.82M

-871.15%-92.91M

-88.01%5.07M

40.00%79.7M

49.31%22.88M

-79.47%2.52M

-33.52%12.05M

Net PPE purchase and sale

----

--0

----

-2,653.85%-716K

--0

----

Net business purchase and sale

----

--0

----

--0

----

Net investment purchase and sale

322.17%21.39M

-162.29%-50.09M

22.09%27.93M

203.12%9.82M

-871.15%-92.91M

-88.01%5.07M

98.77%80.41M

49.31%22.88M

-73.65%3.24M

22.02%12.05M

Cash from discontinued investing activities

Investing cash flow

322.17%21.39M

-162.85%-50.09M

22.09%27.93M

289.10%9.82M

-871.15%-92.91M

-88.01%5.07M

40.00%79.7M

49.31%22.88M

-79.47%2.52M

-33.52%12.05M

Financing cash flow

Cash flow from continuing financing activities

-61.70%13.19M

830.59%135.34M

-418.80%-21.11M

184.27%30.46M

2,005.98%91.54M

1,614.39%34.44M

5,429.66%14.54M

6.62M

9,299.12%10.72M

-4.8M

Net issuance payments of debt

--0

---21.17M

---3.67M

--0

---17.5M

--0

----

Net common stock issuance

-22.35%9.25M

476.92%146.06M

-99.99%2K

-100.02%-2K

--134.15M

--11.91M

--25.32M

--14.79M

--10.53M

--0

Net preferred stock issuance

--0

----

--40M

----

Proceeds from stock option exercised by employees

13,486.21%3.94M

-14.50%2.29M

-89.39%52K

152.46%462K

--1.75M

-98.56%29K

919.77%2.68M

--490K

60.53%183K

--0

Net other financing activities

----

160.51%8.14M

-102.22%-17.5M

--30M

----

---13.46M

---8.65M

--0

----

Cash from discontinued financing activities

Financing cash flow

-61.70%13.19M

830.59%135.34M

-418.80%-21.11M

184.27%30.46M

2,005.98%91.54M

1,614.39%34.44M

5,429.66%14.54M

--6.62M

9,299.12%10.72M

---4.8M

Net cash flow

Beginning cash position

-57.87%31.17M

45.90%73.98M

-14.67%51.81M

-7.65%49.99M

36.99%83.39M

45.90%73.98M

-29.30%50.71M

4.38%60.72M

-19.38%54.13M

2.87%60.87M

Current changes in cash

-47.46%4.87M

-280.76%-43.27M

-250.11%-21.21M

-68.07%2.06M

-387.76%-33.39M

-9.20%9.28M

218.98%23.94M

296.65%14.13M

172.89%6.44M

-185.87%-6.85M

Effect of exchange rate changes

-282.22%-246K

168.52%455K

165.66%568K

-251.66%-229K

-119.00%-19K

370.00%135K

25.89%-664K

-214.55%-865K

205.59%151K

10,100.00%100K

End cash Position

-57.08%35.79M

-57.87%31.17M

-14.67%51.81M

-7.65%49.99M

36.99%83.39M

45.90%73.98M

4.38%60.72M

-19.38%54.13M

Free cash flow

1.75%-29.7M

-80.95%-128.51M

-82.41%-28.03M

-408.39%-38.23M

-127.27%-32.02M

11.20%-30.23M

8.17%-71.02M

31.72%-15.37M

64.60%-7.52M

-38.78%-14.09M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	1.75%-29.7M	-82.79%-128.51M	-82.41%-28.03M	-461.90%-38.23M	-127.27%-32.02M	11.20%-30.23M	9.06%-70.3M	31.72%-15.37M	67.97%-6.8M	-38.78%-14.09M
Net income from continuing operations	11.18%-27.34M	-16.59%-160.28M	-4.87%-28.79M	-80.06%-36.27M	-1.56%-64.43M	-16.50%-30.78M	-77.77%-137.46M	-23.09%-27.45M	8.44%-20.15M	-224.01%-63.44M
Operating gains losses	----	--13.13M	--0	--0	----	----	----	----	----	----
Depreciation and amortization	-7.99%541K	18.29%1.77M	-103.07%-18K	48.38%595K	143.32%601K	127.03%588K	83.19%1.49M	191.54%586K	103.55%401K	24.12%247K
Deferred tax	----	--0	--0	--0	----	----	266.12%26.03M	102.51%109K	100.90%46K	917.35%30.19M
Other non cash items	-138.41%-719K	-49.86%4.06M	-34.00%1.61M	-102.48%-55K	-74.33%630K	90.83%1.87M	251.45%8.09M	412.82%2.44M	263.01%2.22M	482.90%2.45M
Change In working capital	-120.72%-7.57M	-112.22%-3M	-162.01%-4.35M	-164.18%-5.62M	-34.15%10.41M	51.28%-3.43M	564.01%24.54M	935.55%7.02M	225.34%8.76M	50.48%15.8M
-Change in receivables	---10.61M	-34,163.33%-10.22M	-196,700.00%-5.9M	-155,666.67%-4.67M	618.37%352K	--0	-98.93%30K	101.06%3K	-400.00%-3K	-98.37%49K
-Change in inventory	---1.26M	---9.53M	---4.25M	---3.85M	---1.44M	--0	--0	--0	--0	----
-Change in prepaid assets	-47.49%-6.09M	-110.15%-3.13M	-59.89%1.15M	-99.16%123K	-101.75%-269K	-100.73%-4.13M	7,119.36%30.82M	844.68%2.87M	379.78%14.64M	2,338.57%15.36M
-Change in payables and accrued expense	1,241.05%10.94M	739.95%18.44M	-11.00%3.98M	131.94%1.74M	749.39%11.9M	124.73%816K	-156.19%-2.88M	53.80%4.47M	-745.44%-5.45M	-80.74%1.4M
-Change in other working capital	-380.17%-557K	142.05%1.44M	306.56%661K	340.37%1.04M	86.25%-139K	93.04%-116K	9.50%-3.43M	79.50%-320K	64.29%-431K	-150.87%-1.01M
Cash from discontinued investing activities
Operating cash flow	1.75%-29.7M	-82.79%-128.51M	-82.41%-28.03M	-461.90%-38.23M	-127.27%-32.02M	11.20%-30.23M	9.06%-70.3M	31.72%-15.37M	67.97%-6.8M	-38.78%-14.09M
Investing cash flow
Cash flow from continuing investing activities	322.17%21.39M	-162.85%-50.09M	22.09%27.93M	289.10%9.82M	-871.15%-92.91M	-88.01%5.07M	40.00%79.7M	49.31%22.88M	-79.47%2.52M	-33.52%12.05M
Net PPE purchase and sale	----	--0	--0	----	----	----	-2,653.85%-716K	--0	----	----
Net business purchase and sale	----	--0	----	----	----	----	--0	----	----	----
Net investment purchase and sale	322.17%21.39M	-162.29%-50.09M	22.09%27.93M	203.12%9.82M	-871.15%-92.91M	-88.01%5.07M	98.77%80.41M	49.31%22.88M	-73.65%3.24M	22.02%12.05M
Cash from discontinued investing activities
Investing cash flow	322.17%21.39M	-162.85%-50.09M	22.09%27.93M	289.10%9.82M	-871.15%-92.91M	-88.01%5.07M	40.00%79.7M	49.31%22.88M	-79.47%2.52M	-33.52%12.05M
Financing cash flow
Cash flow from continuing financing activities	-61.70%13.19M	830.59%135.34M	-418.80%-21.11M	184.27%30.46M	2,005.98%91.54M	1,614.39%34.44M	5,429.66%14.54M	6.62M	9,299.12%10.72M	-4.8M
Net issuance payments of debt	--0	---21.17M	---3.67M	--0	--0	---17.5M	--0	--0	--0	----
Net common stock issuance	-22.35%9.25M	476.92%146.06M	-99.99%2K	-100.02%-2K	--134.15M	--11.91M	--25.32M	--14.79M	--10.53M	--0
Net preferred stock issuance	--0	----	----	----	----	--40M	----	----	----	----
Proceeds from stock option exercised by employees	13,486.21%3.94M	-14.50%2.29M	-89.39%52K	152.46%462K	--1.75M	-98.56%29K	919.77%2.68M	--490K	60.53%183K	--0
Net other financing activities	----	160.51%8.14M	-102.22%-17.5M	--30M	----	----	---13.46M	---8.65M	--0	----
Cash from discontinued financing activities
Financing cash flow	-61.70%13.19M	830.59%135.34M	-418.80%-21.11M	184.27%30.46M	2,005.98%91.54M	1,614.39%34.44M	5,429.66%14.54M	--6.62M	9,299.12%10.72M	---4.8M
Net cash flow
Beginning cash position	-57.87%31.17M	45.90%73.98M	-14.67%51.81M	-7.65%49.99M	36.99%83.39M	45.90%73.98M	-29.30%50.71M	4.38%60.72M	-19.38%54.13M	2.87%60.87M
Current changes in cash	-47.46%4.87M	-280.76%-43.27M	-250.11%-21.21M	-68.07%2.06M	-387.76%-33.39M	-9.20%9.28M	218.98%23.94M	296.65%14.13M	172.89%6.44M	-185.87%-6.85M
Effect of exchange rate changes	-282.22%-246K	168.52%455K	165.66%568K	-251.66%-229K	-119.00%-19K	370.00%135K	25.89%-664K	-214.55%-865K	205.59%151K	10,100.00%100K
End cash Position	-57.08%35.79M	-57.87%31.17M	-57.87%31.17M	-14.67%51.81M	-7.65%49.99M	36.99%83.39M	45.90%73.98M	45.90%73.98M	4.38%60.72M	-19.38%54.13M
Free cash flow	1.75%-29.7M	-80.95%-128.51M	-82.41%-28.03M	-408.39%-38.23M	-127.27%-32.02M	11.20%-30.23M	8.17%-71.02M	31.72%-15.37M	64.60%-7.52M	-38.78%-14.09M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall